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n recent years, there has been a significant increase in the number of surgical
procedures performed to ablate atrial fibrillation. As a result, a large number of pub-
lications detailing subsequent outcomes after such procedures have resulted. How-
ever, most reports do not address the true effect of the procedure on patient outcomes
and well-being. Second, an additional dilemma regarding the synthesis of literature ad-
dressing surgical ablation is the lack of standardization. Patients are being treated with
different ablation tools and energy sources and different lesion sets, and the follow-up
with subsequent reporting fails to address the difficulties of comparisons between the
programs. The literature also lacks information regarding the correlation between the
success in ablating atrial fibrillation and favorable long-term outcomes. In an attempt
to standardize the reports and improve our understanding as to the real effect of surgical
ablation, Dr Melo established the International Registry for Atrial Fibrillation.
In this issue of the Journal, Melo and colleagues1 discuss 5-year results from the
International Registry for Atrial Fibrillation. After analysis of more than 1700 patients
operated on for mitral valve disease and atrial fibrillation from participating institu-
tions in Europe and the United States, the authors conclude that achievement of stable
sinus rhythm is an excellent predictor for better survival and a decreased incidence of
thromboembolic events. Among the predictors of better survival were smaller left
atrial size, biatrial ablation procedures, the absence of concomitant coronary artery
bypass grafting, and the lack of preoperative permanent atrial fibrillation.
Registries2 generally exist to describe the natural history of disease in a nonrandom-
ized clinical trial setting, pool a large number of similar cases for analyses that would
otherwise be restricted to smaller samples, and provide real-world comparisons of
cost, cost-effectiveness, and patient outcome for new treatment modalities. They should
also provide estimates of long-term follow-up. Registries can be classified according to
the population that was defined. For example, phase IV postmarketing studies sponsored
by the pharmaceutical industry are registries. Health service registries can consist of pa-
tients aggregated by a common procedure, disease, institution, or even insurance payer.
There are several key steps in planning a patient registry, including clearly defining the
purpose of the registry, determining whether this is the appropriate tool to address the
research question, recognizing the stakeholders, delivering a clear definition of the scope
and the target population, assessing the feasibility, and securing the funding. Further-
more, the creation of a registry presents unique and challenging methodological issues.
How are various surgical protocols reconciled and aggregated for analysis? With what
data are reconciliations made and by whom? For every new research hypothesis, will
data aggregation strategies be revisited? Only so much clinical information can be col-
lected by participating institutions before the benefits of participating are outweighed by
the negatives. Additionally, how does the registry cope with data from multiple
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Linstitutions with multiple protocols? Standardization is very
difficult, and if standardization is applied, are all cases before
the registry start date exempt from analysis?
From a statistical viewpoint, the analysis of registry data
presents several issues worth noting. In a randomized clinical
trial the randomization process equally distributes potential con-
founding variables among the study arms. During subsequent
analysis, for reasons beyond the scope of this article, unless
ablockingmethodology is used to ensure a constant, equallydis-
tributed distribution of potential confounders, the analyst need
not waste resources (ie, degrees of freedom) on needless vari-
ables during the modeling process because they have already
been accounted for in the randomization scheme.Unfortunately,
this is not the case when analyzing registry data containingmul-
tiple institutions with multiple protocols. In effect, these institu-
tions represent the blocks that statisticians designing
randomized clinical trials so painstakingly try to achieve. There-
fore every analysis of registry data should begin with a lengthy
exploration of the effects of institution and protocol on the rela-
tionships between suspected predictors and the adverse out-
comes under scrutiny. If no effect is observed, then these
parameters can be discarded, and the real analysis can begin.
But what if institutional effects are observed during the
analysis? Although analyses with large samples will undoubt-
edly reveal differences between small- and large-volume insti-
tutions, statistical control is readily available. Furthermore,
what about the interpretation of data? Should interactive effects
be explored between institutions? Should they even be re-
ported? The analyst is faced with the dilemma of statistical par-
simony or oversaturation. Parsimony is simply achieving the
most efficient statistical analysis by using the fewest resources.
Oversaturation is the phenomenon of overmodeling the data
such that the used statistical algorithms collapse and generate
meaningless or even no results. Registries that serve as obser-
vational studies are wonderful and useful tools in the gathering
of knowledge but require difficult and careful analytic method-
ologies. Lastly, at first glance, one might wonder why author-
ship would pose any issue at all. However, the initial question
to be asked is who owns the data. Obviously, the founders of
the registry have a vested interest in receiving credit for any
published work and rightfully so, but are the data owned by
the registry founders or the participating members?
The study of Melo and colleagues1 published in this issue
reports 5-year results from a large cohort of patients with
mitral valve disease and atrial fibrillation. The authors should
be congratulated for their contribution in establishing such
a large pool of data. But we have to ask ourselves the follow-
ing:What is the real contribution of such registry? The contri-
bution of greatest value of such a registry is epidemiologic in
nature because the study provides us with valuable informa-
tion regarding the number and type of procedures performed
in various centers in Europe and theUnited States. The centers
and the surgeons are well established in the field, and the fol-
lowing issues are not with their surgical expertise. The regis-728 The Journal of Thoracic and Cardiovascular Surgery c Aptry also provides us with information regarding the extent of
different ablative energy source use. However, can we really
draw any conclusion regarding clinical outcomes? There are
10 different centers with various patient-management proto-
cols. The authors clearly state that the study was designed
to assess the clinical and survival benefits of sinus rhythm
recovery in this subset of patients. The report also includes
short- and long-term results detailing survival and the use of
antiarrhythmic therapy with data collected retrospectively.
The registry is composed of a large pool of patients for
which 56 different clinical variables were collected retrospec-
tively, with no report regarding the protocol to treat missing
data. The authors freely admit that centers were allowed to use
their own protocols, resulting in different surgical approaches,
including lesion set, ablation technology, and individual defini-
tions regarding follow-up. As a result, no standardization of the
preoperative assessment, intraoperative management, and post-
operative care was established. Surgeons were allowed to treat
atrial fibrillation surgically according to their own philosophy
without any control. The postoperative management was not
the same for the different centers, rhythm follow-upwas accom-
plished according to some rules, and not all the patients have
been followed by using the same tools (some had repeated elec-
trocardiographic analysis, some had Holter monitoring, and
some had a combination). No guidelines were established with
regard to antiarrhythmic and anticoagulation treatment (and
we know well that some patients still take the medication with-
out any indications for various reasons). These potential biases
and problems are not unique to this registry alone.Asmentioned
earlier, creating a registry poses a challenge on multiple fronts.
This study is a very good example of the challenges we are fac-
ing in the field of the surgical treatment of atrial fibrillation.
The work of Melo and colleagues1 in this issue epitomizes
the current dilemma in assessing the real effect of the surgical
treatment of atrial fibrillation, namely the complete lack of
credibility for the outstanding successes after the maze proce-
dure and its modifications. The newly published Heart
Rhythm Society guidelines3 can serve as a good foundation
to address the steps to establish standardized approaches in
this growing field. We should actively pursue and adopt stan-
dardized definitions for the collection of prospective data
to allow for solid conclusions in the important field of the
surgical treatment for atrial fibrillation.
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